BROOKS — Brooks Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹4.54bn
- IN₹4.60bn
- IN₹825.57m
Annual cashflow statement for Brooks Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -89.9 | -239 | -354 | -196 | -97.9 |
| Depreciation | |||||
| Non-Cash Items | 31.5 | 37.2 | 26.6 | 210 | 128 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 31.6 | -246 | 112 | -129 | -21.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 44.6 | -374 | -145 | -96.8 | 25.2 |
| Capital Expenditures | -56.1 | -232 | -4.67 | -4.39 | -18.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.84 | -16.9 | 9.62 | 6.21 | -441 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -51.3 | -249 | 4.95 | 1.82 | -460 |
| Financing Cash Flow Items | -30.2 | 713 | 154 | -7.96 | -8.33 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.6 | 641 | 114 | 96 | 434 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.88 | 17.2 | -25.8 | 1.02 | -0.821 |